Our clinical trial partnership with the University of Maryland Greenebaum Cancer Center (UMGCC) is in development. The trials listed below are available at Upper Chesapeake Health Kaufman Cancer Center (UCHKCC) and more trials are being opened at our center. For the trials listed below, all the research-related care is done at UCHKCC. For patients who choose to take part in a trial that is only available at UMGCC, all research-related care will take place downtown.
For an updated status of available trials, please contact our Clinical Research Nurse at 443-643-1029. A meeting explaining the trial, or clinical trials in general, can help you decide whether you would like to take part in the study. Participation in a research study is voluntary and you may stop participating at any time for any reason. By agreeing to take part in a research study, you may be required to see the doctor more often and you may be required to have specific blood work or tests. Frequent monitoring is done throughout the study to ensure patient safety.
NSABP-B47: A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer.
CALGB 140503: A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection For Small (< Or Equal To 2 Cm) Peripheral Non-Small Cell Lung Cancer.
To schedule an appointment, please visit our Contact Us page. You don't have to face cancer alone. Call the Cancer LifeNet Helpline at 1-866-393-4355 for support.